Viking Therapeutics Ownership | Who Owns Viking Therapeutics?
Viking Therapeutics Ownership Summary
Viking Therapeutics is owned by 28.19% institutional investors, 2.78% insiders, and 69.02% retail investors. Vanguard group is the largest institutional shareholder, holding 8.89% of VKTX shares. Fidelity Growth Compy Commingled Pl O is the top mutual fund, with 4.61% of its assets in Viking Therapeutics shares.
VKTX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Viking Therapeutics | 28.19% | 2.78% | 69.02% |
| Sector | Healthcare Stocks | 35.58% | 11.87% | 52.55% |
| Industry | Biotech Stocks | 35.75% | 11.83% | 52.41% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Vanguard group | 9.98M | 8.89% | $351.25M |
| Blackrock funding, inc. /de | 6.88M | 6.04% | $223.88M |
| Blackrock | 6.03M | 5.82% | $319.45M |
| Fmr | 6.02M | 5.28% | $196.05M |
| Two sigma investments, lp | 4.43M | 3.89% | $144.22M |
| State street | 4.40M | 3.86% | $143.03M |
| Morgan stanley | 3.01M | 2.64% | $98.07M |
| Geode capital management | 2.08M | 1.83% | $67.77M |
| American century companies | 2.08M | 1.82% | $67.64M |
| Raymond james financial | 2.08M | 1.82% | $113.51M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Act capital management | 209.30K | 5.35% | $6.81M |
| First washington | 385.37K | 3.55% | $12.54M |
| Diadema partners lp | 525.18K | 2.91% | $17.09M |
| Profit investment management | 18.00K | 2.56% | $633.07K |
| Blackbarn capital partners lp | 621.45K | 1.63% | $20.22M |
| Persistent asset partners | 133.07K | 1.61% | $4.33M |
| Toms capital investment management lp | 763.60K | 1.52% | $40.48M |
| Artia global partners lp | 180.73K | 1.30% | $5.88M |
| Maso capital partners | 25.00K | 1.08% | $657.00K |
| Quantum private wealth | 105.14K | 1.06% | $3.42M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Two sigma investments, lp | 4.43M | 0.12% | 2.00M |
| American century companies | 2.08M | 0.03% | 1.77M |
| Norges bank | 1.28M | 0.01% | 1.28M |
| Raymond james financial | 2.08M | 0.04% | 1.15M |
| Vestal point capital, lp | 914.15K | 0.83% | 914.15K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Avoro capital advisors | - | - | -3.59M |
| Blackrock | 6.03M | 0.01% | -2.25M |
| Massachusetts financial services co /ma/ | - | - | -1.36M |
| Perpetual | - | - | -1.27M |
| Westfield capital management co lp | - | - | -930.37K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Norges bank | 1.28M | 0.01% | 1.28M | $51.46M |
| Vestal point capital, lp | 914.15K | 0.83% | 914.15K | $29.75M |
| Toms capital investment management lp | 763.60K | 1.52% | 763.60K | $40.48M |
| Vanguard fiduciary trust | 710.41K | 0.01% | 710.41K | $23.12M |
| Baker bros. advisors lp | 366.08K | 0.07% | 366.08K | $9.62M |
Sold Out
| Holder | Change |
|---|---|
| True wealth design | -1.00 |
| Cullen/frost bankers | -2.00 |
| Mather group, llc. | -3.00 |
| Eastern bank | -4.00 |
| Concord wealth partners | -5.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 295 | -36.01% | 32,143,576 | -55.31% | 28 | 0.69% | 149 | -32.58% | 76 | -45.71% |
| Dec 31, 2025 | 295 | -26.62% | 42,499,369 | -40.36% | 37 | 0.94% | 135 | -31.82% | 94 | -12.15% |
| Sep 30, 2025 | 387 | -6.52% | 69,883,492 | -2.34% | 62 | 1.53% | 194 | -15.28% | 101 | -5.61% |
| Jun 30, 2025 | 413 | 1.72% | 76,058,977 | 0.09% | 67 | 1.48% | 224 | -0.44% | 108 | 3.85% |
| Mar 31, 2025 | 402 | -10.67% | 76,083,022 | -7.14% | 67 | 1.24% | 220 | -5.98% | 105 | -16.67% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Growth Compy Commingled Pl O | 5.10M | 4.61% | 70.32K |
| Vanguard Total Stock Mkt Idx Inv | 3.52M | 3.03% | 11.04K |
| Vanguard US Total Market Shares ETF | 3.32M | 2.96% | 2.50K |
| State Street® SPDR® S&P® Biotech ETF | 2.64M | 2.28% | -26.13K |
| Vanguard Small Cap Index | 2.53M | 2.18% | -5.62K |
| SPDR® S&P Biotech ETF | 1.92M | 1.71% | 4.29K |
| American Century US Opport. Mid Cap Gr | 1.57M | 1.35% | 1.57M |
| American Century Heritage Inv | 1.57M | 1.35% | 1.57M |
| Vanguard Small Cap Growth Index Inv | 1.42M | 1.22% | -775.00 |
| Jupiter Merian Glb Eq AbsRet I USD Acc | 1.30M | 1.12% | 1.30M |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Mar 10, 2026 | Aubuchon Neil William | Chief Commercial Officer | Buy | $149.91K |
| Jan 05, 2026 | ZANTE GREG | Chief Financial Officer | Sell | $464.02K |
| Jan 05, 2026 | ZANTE GREG | Chief Financial Officer | Sell | $352.63K |
| Jan 05, 2026 | ZANTE GREG | Chief Financial Officer | Sell | $1.03M |
| Jan 05, 2026 | ZANTE GREG | Chief Financial Officer | Sell | $48.13K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | 1 | 13 |
| 2025 Q4 | - | 4 |
| 2025 Q3 | - | 3 |
| 2025 Q2 | - | - |
| 2025 Q1 | 1 | 6 |
VKTX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools